期刊
CHEST
卷 138, 期 2, 页码 393-406出版社
ELSEVIER SCIENCE BV
DOI: 10.1378/chest.09-2622
关键词
-
资金
- Netherlands Asthma Foundation [NAF 34 05 038]
- Cancer Research UK [A7098, A6135, A6835, A5738]
- Brimingham Children's Hospital Research Foundation, England [102f]
- Institute for the Stimulation of Innovation by Science and Technology, Belgium [070699]
Background: Research into the association between diabetes and pulmonary function has resulted in inconsistent outcomes among studies. We performed a metaanalysis to clarify this association. Methods: From a systematic search of the literature, we included 40 studies describing pulmonary function data of 3,182 patients with diabetes and 27,080 control subjects. Associations were summarized pooling the mean difference (MD) (standard error) between patients with diabetes and control subjects of all studies for key lung function parameters. Results: For all studies, the pooled MD for FEV1, PVC, and diffusion of the lungs for carbon monoxide were -5.1 (95% CI, -6.4 to 3.7; P < .001), -6.3 (95% CI, -8.0 to -4.7; P < .001), and 7.2 (95% CI, 10.0 to -4.4; P < .001) % predicted, respectively, and for FEV1/FVC 0.1% (95% CI, -0.8 to 1.0; P = .78). Metaregression analyses showed that between-study heterogeneity was not explained by BNB, smoking, diabetes duration, or glycated hemoglobin (all P > .05). Conclusions: Diabetes is associated with a modest, albeit statistically significant, impaired pulmonary function in a restrictive pattern. Since our results apply to the diabetic subpopulation free from overt pulmonary disease, it would next be interesting to investigate the potential clinical implications in those patients with diabetes who carry a pulmonary diagnosis, such as COPD or asthma. CHEST 2010; 138(2):393-406
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据